These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28871116)

  • 1. Controlling Directed Protein Interaction Networks in Cancer.
    Kanhaiya K; Czeizler E; Gratie C; Petre I
    Sci Rep; 2017 Sep; 7(1):10327. PubMed ID: 28871116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering Indispensable Proteins in Controlling Directed Human Protein Interaction Network.
    Zhang X
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):2074-2078. PubMed ID: 29994604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controllability in cancer metabolic networks according to drug targets as driver nodes.
    Asgari Y; Salehzadeh-Yazdi A; Schreiber F; Masoudi-Nejad A
    PLoS One; 2013; 8(11):e79397. PubMed ID: 24282504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of housekeeping and tissue-specific driver nodes in human protein interaction networks.
    Zhang XF; Ou-Yang L; Dai DQ; Wu MY; Zhu Y; Yan H
    BMC Bioinformatics; 2016 Sep; 17(1):358. PubMed ID: 27612563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Target Controllability of Linear Networks.
    Czeizler E; Wu KC; Gratie C; Kanhaiya K; Petre I
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(4):1217-1228. PubMed ID: 29994605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network controllability analysis of intracellular signalling reveals viruses are actively controlling molecular systems.
    Ravindran V; Nacher JC; Akutsu T; Ishitsuka M; Osadcenco A; Sunitha V; Bagler G; Schwartz JM; Robertson DL
    Sci Rep; 2019 Feb; 9(1):2066. PubMed ID: 30765882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel algorithm for finding optimal driver nodes to target control complex networks and its applications for drug targets identification.
    Guo WF; Zhang SW; Shi QQ; Zhang CM; Zeng T; Chen L
    BMC Genomics; 2018 Jan; 19(Suppl 1):924. PubMed ID: 29363426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network controllability solutions for computational drug repurposing using genetic algorithms.
    Popescu VB; Kanhaiya K; Năstac DI; Czeizler E; Petre I
    Sci Rep; 2022 Jan; 12(1):1437. PubMed ID: 35082323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical controllability analysis of directed biological networks using efficient graph reduction.
    Ishitsuka M; Akutsu T; Nacher JC
    Sci Rep; 2017 Oct; 7(1):14361. PubMed ID: 29084972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovering driver nodes in chronic kidney disease-related networks using Trader as a newly developed algorithm.
    Masoudi-Sobhanzadeh Y; Gholaminejad A; Gheisari Y; Roointan A
    Comput Biol Med; 2022 Sep; 148():105892. PubMed ID: 35932730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WDNfinder: A method for minimum driver node set detection and analysis in directed and weighted biological network.
    Chu Y; Wang Z; Wang R; Zhang N; Li J; Hu Y; Teng M; Wang Y
    J Bioinform Comput Biol; 2017 Oct; 15(5):1750021. PubMed ID: 28918707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NetControl4BioMed: a pipeline for biomedical data acquisition and analysis of network controllability.
    Kanhaiya K; Rogojin V; Kazemi K; Czeizler E; Petre I
    BMC Bioinformatics; 2018 Jul; 19(Suppl 7):185. PubMed ID: 30066633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target controllability with minimal mediators in complex biological networks.
    Ebrahimi A; Nowzari-Dalini A; Jalili M; Masoudi-Nejad A
    Genomics; 2020 Nov; 112(6):4938-4944. PubMed ID: 32905831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational discovery of dynamic cell line specific Boolean networks from multiplex time-course data.
    Razzaq M; Paulevé L; Siegel A; Saez-Rodriguez J; Bourdon J; Guziolowski C
    PLoS Comput Biol; 2018 Oct; 14(10):e1006538. PubMed ID: 30372442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Driver Nodes in the Human Signaling Network Using Structural Controllability Analysis.
    Liu X; Pan L
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(2):467-72. PubMed ID: 26357232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characteristics in network control of molecular multiplex networks.
    Yuan C; Qian ZY; Zhou J; Chen SM; Nie S
    PLoS One; 2023; 18(3):e0283768. PubMed ID: 36996151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of quantitative proteomics data and interaction networks: Identification of dysregulated cellular functions during cancer progression.
    Zanzoni A; Brun C
    Methods; 2016 Jan; 93():103-9. PubMed ID: 26386316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practically efficient algorithm for identifying critical control proteins in directed probabilistic biological networks.
    Tokuhara Y; Akutsu T; Schwartz JM; Nacher JC
    NPJ Syst Biol Appl; 2024 Aug; 10(1):87. PubMed ID: 39134558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimum steering node set of complex networks and its applications to biomolecular networks.
    Wu L; Li M; Wang J; Wu FX
    IET Syst Biol; 2016 Jun; 10(3):116-23. PubMed ID: 27187990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.